These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series. Lunardi G, Armirotti A, Nicodemo M, Cavallini L, Damonte G, Vannozzi MO, Venturini M. Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140 [Abstract] [Full Text] [Related]
30. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Baptista JP, Sousa E, Martins PJ, Pimentel JM. Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742 [Abstract] [Full Text] [Related]
31. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis. Rider TR, Silinskie KM, Hite MS, Bress J. Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291 [Abstract] [Full Text] [Related]
32. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients? Udy AA, Covajes C, Taccone FS, Jacobs F, Vincent JL, Lipman J, Roberts JA. Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944 [Abstract] [Full Text] [Related]
38. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients. Petejova N, Martinek A, Zahalkova J, Duricova J, Brozmanova H, Urbanek K, Grundmann M, Kacirova I. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):342-7. PubMed ID: 22660225 [Abstract] [Full Text] [Related]